Dextroamphetamine, like other amphetamines, elicits its stimulating results through several distinctive steps: it inhibits or reverses the transporter proteins for that monoamine neurotransmitters (particularly the serotonin, norepinephrine and dopamine transporters) both by means of trace amine-related receptor one (TAAR1) or in the TAAR1 independ